|
Dimension 4: Crude and adjusted associations between patient characteristics and patients' evaluation of aspects of the organisation of care. |
|||||||||
| 100% positive assessments 1 |
0–49% positive assessments 2 |
||||||||
|
|
|||||||||
| Prev.(%) |
PR |
Adj. PR |
95% CI |
Prev.(%) |
PR |
Adj. PR |
95% CI |
||
|
|
|||||||||
| Gender |
|||||||||
| (N = 24154) |
Female |
64.5 |
1 |
13 |
23.4 |
1 |
1 |
||
| Male |
68.3 |
1.06 |
1.01 |
0.99 – 1.03 |
19.4 |
0.83 |
0.91 |
0.85 – 0.96 |
|
|
|
|||||||||
| Age (years) |
|||||||||
| (N = 24154) |
18–24 |
58.4 |
1 |
13 |
28.1 |
1 |
1 |
||
| 25–29 |
55.8 |
0.96 |
0.95 |
0.89 – 1.01 |
28.9 |
1.03 |
1.04 |
0.93 – 1.17 |
|
| 30–34 |
58.6 |
1.00 |
1.00 |
0.95 – 1.07 |
27.0 |
1.00 |
0.94 |
0.84 – 1.05 |
|
| 35–39 |
60.0 |
1.03 |
1.05 |
0.99 – 1.11 |
25.2 |
1.01 |
0.85 |
0.76 – 0.95 |
|
| 40–44 |
62.0 |
1.06 |
1.11 |
1.04 – 1.18 |
24.3 |
1.00 |
0.78 |
0.69 – 0.89 |
|
| 45–49 |
61.8 |
1.06 |
1.12 |
1.05 – 1.19 |
25.3 |
0.90 |
0.80 |
0.70 – 0.91 |
|
| 50–54 |
65.5 |
1.12 |
1.20 |
1.13 – 1.28 |
22.2 |
0.88 |
0.68 |
0.60 – 0.78 |
|
| 55–59 |
68.7 |
1.18 |
1.27 |
1.20 – 1.35 |
20.3 |
0.74 |
0.62 |
0.55 – 0.70 |
|
| 60–64 |
71.6 |
1.23 |
1.33 |
1.25 – 1.41 |
18.0 |
0.67 |
0.55 |
0.48 – 0.64 |
|
| 65–69 |
76.3 |
1.31 |
1.42 |
1.34 – 1.50 |
14.9 |
0.58 |
0.46 |
0.39 – 0.53 |
|
| 70–74 |
77.7 |
1.33 |
1.44 |
1.36 – 1.53 |
14.9 |
0.53 |
0.46 |
0.39 – 0.55 |
|
| 75–79 |
76.1 |
1.30 |
1.43 |
1.34 – 1.52 |
14.5 |
0.51 |
0.44 |
0.37 – 0.52 |
|
| 80+ |
76.5 |
1.31 |
1.44 |
1.36 – 1.54 |
16.3 |
0.57 |
0.48 |
0.41 – 0.57 |
|
|
|
|||||||||
| Further education (years) |
|||||||||
| (N = 23058) |
None |
68.5 |
1 |
1 |
20.4 |
1 |
1 |
||
| Less than 2 |
65.1 |
0.96 |
1.00 |
0.96 – 1.03 |
22.2 |
1.09 |
1.00 |
0.90 – 1.11 |
|
| 2–4 |
64.6 |
0.84 |
0.97 |
0.95 – 1.00 |
22.8 |
1.12 |
1.07 |
0.99 – 1.15 |
|
| 5 or more |
64.8 |
0.79 |
0.98 |
0.95 – 1.01 |
23.0 |
1.13 |
1.11 |
1.00 – 1.22 |
|
| Undergoing education or other |
67.8 |
0.85 |
1.05 |
1.01 – 1.10 |
20.5 |
1.00 |
0.94 |
0.81 – 1.08 |
|
|
|
|||||||||
| Frequency of attendance (times per year) |
|||||||||
| (N = 24154) |
0–1 |
66.1 |
1 |
13 |
24.3 |
1 |
1 |
||
| 2–3 |
64.3 |
0.97 |
0.99 |
0.96 – 1.03 |
24.4 |
1.00 |
0.96 |
0.88 – 1.05 |
|
| 4–5 |
65.1 |
0.98 |
1.01 |
0.97 – 1.04 |
22.5 |
0.93 |
0.87 |
0.80 – 0.95 |
|
| 6–7 |
65.7 |
0.99 |
1.04 |
1.00 – 1.08 |
21.2 |
0.87 |
0.78 |
0.70 – 0.86 |
|
| 8–9 |
68.0 |
1.03 |
1.08 |
1.03 – 1.13 |
19.4 |
0.80 |
0.70 |
0.62 – 0.80 |
|
| 10+ |
68.2 |
1.03 |
1.12 |
1.08 – 1.17 |
18.7 |
0.77 |
0.63 |
0.57 – 0.69 |
|
|
|
|||||||||
| Duration of listing (years) |
|||||||||
| (N = 16168) |
Less than 1 |
65.6 |
1 |
13 |
25.8 |
1 |
1 |
||
| 1–2 |
64.8 |
0.99 |
0.97 |
0.92 – 1.02 |
23.8 |
0.92 |
0.97 |
0.86 – 1.10 |
|
| 3–7 |
65.6 |
1.00 |
0.96 |
0.92 – 1.01 |
21.9 |
0.85 |
0.92 |
0.82 – 1.04 |
|
| 8–12 |
68.1 |
1.04 |
0.98 |
0.93 – 1.03 |
20.2 |
0.78 |
0.89 |
0.78 – 1.01 |
|
| 13+ |
70.7 |
1.08 |
1.00 |
0.95 – 1.05 |
17.5 |
0.68 |
0.79 |
0.69 – 0.90 |
|
|
|
|||||||||
| Self-rated health |
|||||||||
| (N = 24154) |
Excellent |
70.0 |
1 |
13 |
19.6 |
1 |
1 |
||
| Very good |
67.1 |
0.96 |
0.92 |
0.89 – 0.95 |
21.2 |
1.08 |
1.18 |
1.07 – 1.30 |
|
| Good |
66.3 |
0.95 |
0.82 |
0.79 – 0.84 |
21.8 |
1.11 |
1.51 |
1.37 – 1.65 |
|
| Fair |
61.1 |
0.87 |
0.71 |
0.69 – 0.74 |
25.3 |
1.29 |
2.02 |
1.82 – 2.24 |
|
| Poor |
60.8 |
0.87 |
0.70 |
0.65 – 0.74 |
25.1 |
1.28 |
2.11 |
1.82 – 2.44 |
|
|
|
|||||||||
| Chronic condition |
|||||||||
| (N = 23810) |
No |
64.9 |
1 |
13 |
23.4 |
1 |
1 |
||
| Yes-KRTC |
71.2 |
1.10 |
1.03 |
1.01 – 1.06 |
17.9 |
0.77 |
0.88 |
0.81 – 0.96 |
|
| Yes-other or multiple |
63.8 |
0.98 |
1.00 |
0.98 – 1.03 |
22.7 |
0.97 |
0.93 |
0.88 – 1.00 |
|
|
|
|||||||||
| Chronic condition |
|||||||||
| (N = 16049) |
None |
64.9 |
1 |
13 |
23.4 |
1 |
1 |
||
| K – Cardiovascular |
66.3 |
1.14 |
1.05 |
1.01 – 1.09 |
19.8 |
0.68 |
0.85 |
0.76 – 0.96 |
|
| R – Respiratory |
73.8 |
1.02 |
1.02 |
0.97 – 1.07 |
16.0 |
0.95 |
0.96 |
0.85 – 1.09 |
|
| T – Endocrine |
66.2 |
1.09 |
1.03 |
0.99 – 1.08 |
22.1 |
0.81 |
0.92 |
0.80 – 1.07 |
|
| C – Cancer |
70.5 |
1.16 |
1.12 |
1.04 – 1.21 |
18.8 |
0.56 |
0.62 |
0.46 – 0.84 |
|
|
Prevalence ratio (PR) for 100% positive assessments and for 0–49% positive assessments associated with different patient characteristics. Crude PRs are adjusted for clustering of patients. Adjusted PRs are adjusted for patients' gender, age, frequency of attending a GP, self-rated health and clustering of patients. Numbers in italics are used to indicate statistical significance. 1 Patients who marked 100% of the answered questions in one of the two most positive answering categories. 2 Patients who marked less than 50% (0–49%) of the answered questions in one of the two most positive answering categories. 3 Poisson regression with robust variance | |||||||||
Heje et al. BMC Health Services Research 2008 8:178 doi:10.1186/1472-6963-8-178 |
|||||||||